Mutations in the GTPCH1 gene (GCH1) are associated with malignant phenylketonuria and hyperphenylalaninemia, as well as L-DOPA (Levodopa)-responsive dystonia [7]–[9]. This evidence concerns the gene GCH1 and Hyperphenylalaninemia.